● Recruiting

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Condition: Erectile Dysfunction Following Radical Prostatectomy · Erectile Dysfunction · Prostate Cancer · Sponsor: Biozeus Biopharmaceutical S.A.

PhasePhase 2

Planned participants72

Who can joinMale, 40 Years to 65 Years

Healthy volunteersNo

About this study

To determine efficacy, safety and tolerabiltiy of topically applied BZ371A in patients that experienced RP, in combination with daily tadalafil compared to placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Camilla NR Trindade, PhD · +55(21)2523-9089 · camilla.nunes@biozeus.com.br

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Urológica

Belo Horizonte, Brazil

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05558007